Peripheral blood stem cell collection in elderly patients

Annals of Hematology

Volumn 89, Issue 3, 2010, Pages 317-321

  Tempescul, Adrian ^a   Ianotto, Jean Christophe ^a   Hardy, Elisabeth ^b   Quivoron, Francoise ^b   Petrov, Ljubomir ^c   Berthou, Christian ^a  

^a CHU MORVAN   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

Author keywords

Lymphoma; Myeloma; Stem cell harvest

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; BORTEZOMIB; DNA TOPOISOMERASE INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCALATING AGENT; CD34 ANTIGEN;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CD34 SELECTION; CHILD; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GERIATRIC PATIENT; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STEM CELL MOBILIZATION; AGE; CELL COUNT; METHODOLOGY; MULTIPLE MYELOMA; STANDARD;

AGE FACTORS; AGED; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; CELL COUNT; FEASIBILITY STUDIES; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LYMPHOMA; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES;

EID: 77949330708     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0812-9     Document Type: Article

References (19)

1. Schmitz N, Buske C, Gisselbrecht C (2007) Autologous stem cell transplantation in lymphoma. Semin Hematol 44(4):234-245. doi:10.1053/j. seminhematol.2007.08.007 Review (Pubitemid 47603190)
2. Harousseau JL (2007) Role of stem cell transplantation. Hematol Oncol Clin North Am 21(6):1157-1174. doi:10.1016/j.hoc. 2007.08.001 Review
3. Jantunen E, Canals C, Rambaldi A, Ossenkoppele G, Allione B, Blaise D, Conde E, Tilly H, Cook G, Clark F, Gallamini A, Haynes A, Mounier N, Dreger P, Pfreundschuh M, Sureda A; for the EBMT Lymphoma Working Party (2008) Autologous stem cell transplantation in elderly patients (>=60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation Registry. Haematologica 93 (12):1837-1842
4. Reimer P, Rüdiger T, Geissinger E, Weissinger F, Nerl C, Schmitz N, Engert A, Einsele H, Müller-Hermelink HK, Wilhelm M (2009) Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol 27(1):106-113
5. Morschhauser F, Brice P, Fermá C, DivináM, Salles G, Bouabdallah R, Sebban C, Voillat L, Casasnovas O, Stamatoullas A, Bouabdallah K, Andrá M, Jais JP, Cazals-Hatem D, Gisselbrecht C (2008) Riskadapted salvage treatmentwith single or tandemautologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/ SFGM Study Group. J Clin Oncol 26(36):5980-5987
6. Espigado I, Ríos E, Marín-Niebla A, Carmona M, Parody R, Párez-Hurtado JM, Márquez FJ, Urbano-Ispizua A (2008) High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. Transplant Proc 40(9):3104-3105. doi:10.1016/j. transproceed.2008.08.092
7. Carella AM, Bellei M, Brice P, Gisselbrecht C, Visani G, Colombat P, Fabbiano F, Donelli A, Luminari S, Feugier P, Browett P, Hagberg H, Federico M (2009) High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long term results. Haematologica 94(1):146-148
8. Gyan E, Foussard C, Bertrand P, Michenet P, Le Gouill S, Berthou C, Maisonneuve H, Delwail V, Gressin R, Quittet P, Vilque JP, Desablens B, Jaubert J, Ramee JF, Arakelyan N, Thyss A, Molucon-Chabrot C, Delepine R, Milpied N, Colombat P, Deconinck E (2009) High dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: arandomized multicenter study by the GOELAMS. Final results with a median follow-up of nine years. Blood 113(5):995-1001. doi:10.1182/blood-2008-05-160200
9. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, Gratwohl A, Madrigal A, Niederwieser D, Passweg J, Rocha V, Saccardi R, Schouten H, Schmitz N, Socie G, Sureda A, Apperley J, European Group for Blood and Marrow (2006) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 37 (5):439-449. doi:10.1038/sj.bmt.1705265
10. Gertz MA, Ansell SM, Dingli D, Dispenzieri A, Buadi FK, Elliott MA, Gastineau DA, Hayman SR, Hogan WJ, Inwards DJ, Johnston PB, Kumar S, Lacy MQ, Leung N, Micallef IN, Porrata LF, Schafer BA, Wolf RC, Litzow MR (2008) Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clin Proc 83(10):1131-1138. doi:10.4065/83.10.1131
11. Mehta J, Singhal S (2008) Current status of autologous hematopoietic stem cell transplantation in myeloma. Bone Marrow Transplant 42 (Suppl 1):S28-S34. doi:10.1038/bmt.2008.109 Review
12. Olivieri A, Capelli D, Montanari M, Brunori M, Massidda D, Poloni A, Lucesole M, Centurioni R, Candela M, Masia MC, Tonnini C, Leoni P (2001) Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. Bone Marrow Transplant 27(11):1189-1195. doi:10.1038/sj.bmt.1703034 (Pubitemid 32600292)
13. Mileshkin LR, Seymour JF, Wolf MM, Gates P, Januszewicz EH, Joyce P, Prince HM (2005) Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older. Leuk Lymphoma 46(11):1575-1579. doi:10.1080/10428190500235884 (Pubitemid 41700990)
14. Ferrara F, Viola A, Copia C, Falco C, D'Elia R, Tambaro FP, Correale P, D'Amico MR, Vicari L, Palmieri S (2007) Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia. Hematol Oncol 25(2):84-89. doi:10.1002/hon.810 (Pubitemid 46972835)
15. Cottler-Fox M, Lapidot T (2006) Mobilizing the older patient with myeloma. Blood Rev 20(1):43-50. doi:10.1016/j.blre.2005.06.001 Review (Pubitemid 43106717)
16. Fietz T, Rieger K, Dimeo F, Blau IW, Thiel E, Knauf WU (2004) Stem cell mobilization in multiple myeloma patients: do we need an age-adjusted regimen for the elderly? J Clin Apher 19(4):202-207. doi:10.1002/jca.20030 (Pubitemid 40165062)
17. Perea G, Sureda A, Martino R, Altás A, Martínez C, Cabezudo E, Amill B, Martín-Henao GA, González Y, Muñoz L, Peyret M, Brunet S, Sierra J (2001) Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma. Ann Hematol 80(10):592-597. doi:10.1007/s002770100351 (Pubitemid 33061999)
18. Ikeda K, Kozuka T, Harada M (2004) Factors for PBPC collection efficiency and collection predictors. Transfus Apheresis Sci 31 (3):245-259. doi:10.1016/j.transci.2004.09.008 Review (Pubitemid 39535521)
19. Lysák D, Koza V, Jindra P (2005) Factors affecting PBSC mobilization and collection in healthy donors. Transfus Apheresis Sci 33(3):275-283. doi:10.1016/j.transci.2005.07.007 (Pubitemid 41586193)